Selentus Science is pleased to announce that its patent for TenaTac®, an innovative, adhesive surgical haemostat, has been allowed for grant in the UK, following an earlier grant in the USA. TenaTac is a Class III CE marked medical device that was approved for human surgical use in late 2019. TenaTac is now also available to veterinary surgeons in the UK; for further information please visit www.Selentus.com
This article was written by Medilink EM Member, Selentus Science.
